Wearable Monitoring and Therapy Systems
- General Details
This strategic patent portfolio covers next-generation wearable medical devices, digital health systems, neurotechnology, and AI-driven health monitoring platforms designed for continuous, non-invasive monitoring through the ear. The patented technologies utilize advanced in-ear sensors to capture clinical-grade physiological signals, including EEG, ECG, EOG, pulse oximetry, and blood flow data, enabling more accurate monitoring than traditional wrist-based wearables. The portfolio includes intellectual property for multiple high-growth healthcare and consumer technology markets, including wearable health monitoring, sleep monitoring, brain-computer interface (BCI), neuromodulation, migraine management, cardiac monitoring, and digital therapeutics.
Key applications include in-ear health monitoring systems for tracking brain activity, heart activity, eye movement, oxygen levels, and sleep quality; wearable sleep apnea detection and sleep stage monitoring; automated detection and treatment systems for neurological and neuropsychiatric disorders; migraine and cluster headache prediction and therapy; and closed-loop cardiac arrhythmia monitoring with automated neuromodulation. The technologies are designed in compact earbud-style and hearing-aid-style wearable formats suitable for continuous ambulatory use, remote patient monitoring, and at-home healthcare applications. The portfolio also includes patented brain-computer interface functionality for robotics, gaming, assistive mobility devices, and hands-free device control.
- Patent Portfolio
The IP and assets available for sale include:
- US 12,543,961 – Auricular Health Monitoring and Brain-Computer Interface Systems (Issued: 02/10/2026).
- US 12,594,026 – Auricular Sleep Monitoring Systems and Ear-Canal Pulse Oximeter (Issued: 04/07/2026).
- US 12,642,486 – Auricular Electroencephalogram (EEG) and Automatic Remedy Systems for Neuropsychiatric Disorders (Issued: 06/02/2026).
- US Application 19/637,692 – Automatic Detection-Therapy Systems for Neuropsychiatric Disorders.
- US Application 19/647,337 – Automatic Detection-Therapy Systems for Migraine and Cluster Headache and Neurovascular Monitoring System.
- US Application 19/660,889 – Automatic Detection-Therapy Systems for Cardiac Arrhythmias and Cardiovascular Monitoring System.
- US Application 19/332,747 – Wearable Electrocardiogram (ECG) Systems and Automatic Anti-Arrhythmia Systems.
- Data Room Access & Additional Details
Other Public Data Room Materials Available at VIP-3610 Public Data Room for Wearable Monitoring and Therapy Systems IP:
- Introductory Materials
- Patents and Applications
- Patents and Applications File Histories
- Patent Assignment and Ownership
Additional Materials (available upon signing a mutual non-disclosure agreement):
- Due Diligence Review
- More Information
Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Charlette Hunter at Vibrant IP, LLC at charlette@vibrantip.com and +1 404-482-3652.

